In a report issued yesterday, analyst Liana Moussatos of Wedbush reiterated an Outperform rating on Pacira Pharmaceuticals (NASDAQ:PCRX) with a $110 price target, following strong July Symphony Health …
In a research report released yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform on La Jolla Pharmaceutical (LJPC) with a $45 price target, …
In a research report released yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Lexicon Pharmaceuticals (LXRX) with a $4 price target, …
In a research report published yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Lexicon Pharmaceuticals (LXRX) with a $4 price target …
In a research note issued Tuesday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on XOMA Corporation (XOMA) and a price target of $14.00, following the news that the last exacerbation event for …
In a research note issued Thursday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on La Jolla Pharmaceutical Co. (LJPC) and a price target of $34.
